Australia releases guidance on Class III devices and active implantables:
This article was originally published in Clinica
Australia's Therapeutic Goods Administration (TGA) has published "Australian Medical Devices Guidance Document 13 - variants for Class III and AIMD Medical Devices", which addresses the criteria for entering Class III and active implantable medical devices in the Australian Register of Therapeutic Goods (ARTG). It covers "same kind of medical device", unique product identifiers and variants. The document is one of a series explaining key areas of the new regulatory system for medical devices. The guidance is available via: www.tga.gov.au/new/new.htm
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.